/West%20Pharmaceutical%20Services%2C%20Inc_%20logo%20on%20phone-by%20rafapress%20via%20Shutterstock.jpg)
Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs and manufactures containment and delivery systems for injectable drugs and healthcare products. With a market cap of $23.5 billion, West Pharmaceutical’s operations span the Americas, Europe, Asia, Africa, and Australia. West Pharmaceutical is expected to announce its Q2 earnings on Thursday, July 25.
Ahead of the event, analysts expect West Pharmaceutical to report a profit of $1.78 per share, down 15.6% from $2.11 per share reported in the year-ago quarter. The company has consistently surpassed Wall Street’s EPS estimates for the past four quarters. Its EPS for the last reported quarter decreased 21.2% year over year to $1.56. However, it beat the consensus estimate by 20.9%.